These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15720090)

  • 1. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Pushing Rate on Foam Stability in the Tessari Method.
    Azmoun S; Liu Y; Bian K; Chen A; Liu S
    Dermatol Surg; 2024 Jun; 50(6):542-545. PubMed ID: 38460194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Stability of Physician-Compounded Foam is Influenced by the Angle of Connector.
    Shi X; Liu Y; Li D; Tursun M; Azmoun S; Liu S
    Ann Vasc Surg; 2024 Feb; 99():217-222. PubMed ID: 37852364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of catheter needle caliber on polidocanol foam stability in foam sclerotherapy.
    Azmoun S; Liu Y; Tursun M; Liu S
    Front Neurol; 2024; 15():1417788. PubMed ID: 38841699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compression sclerotherapy for primary valvular insufficiency -from liquid to foam-.
    Yamaki T
    Ann Vasc Dis; 2010; 3(1):37-45. PubMed ID: 23555386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and ex vivo evaluation of the biological performance of sclerosing foams.
    Bottaro E; Paterson JAJ; Quercia L; Zhang X; Hill M; Patel VA; Jones SA; Lewis AL; Millar TM; Carugo D
    Sci Rep; 2019 Jul; 9(1):9880. PubMed ID: 31285447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Foam and Liquid Sclerotherapy for Lower Extremity Reticular and Telangiectatic Veins: A Single-Center Retrospective Study.
    Verma KK; Friedmann DP
    Dermatol Surg; 2024 Jun; ():. PubMed ID: 38860828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empty vein ablation (EVA) technique: an in-vivo animal model to assess the effects of sclerosing agent concentration and wall contact time on intima and media tunicae structure.
    Salerno M; Bissacco D; Chi YW; Narayanan S; Addis A; Dellavia C; Canciani E; Righini PC; Nano G; Gianesini S
    Int Angiol; 2024 Apr; 43(2):223-228. PubMed ID: 38512703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions For the Treatment of Lower Limb Telangiectasias and Reticular Veins: A Systematic Review and Network Meta-Analysis.
    Bontinis V; Bontinis A; Koutsoumpelis A; Claridge M; Chorti A; Rafailidis V; Giannopoulos A; Ktenidis K
    Eur J Vasc Endovasc Surg; 2023 Oct; 66(4):560-576. PubMed ID: 37209995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Treatment of Orbital Lymphatic Malformation Using Foam Sclerotherapy with 3% Sodium Tetradecyl Sulfate: A Case Report.
    Jung H; Choi HY; Lee H; Park J
    Korean J Ophthalmol; 2024 Apr; 38(2):167-169. PubMed ID: 38351483
    [No Abstract]   [Full Text] [Related]  

  • 11. Low temperature offers better foam stability.
    Serkan M; Gokay D
    J Cosmet Dermatol; 2024 Oct; 23(10):3366-3371. PubMed ID: 38837644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical injection of sclerosant to treat cheek subcutaneous venous malformation resulting in blindness: a case report.
    Cui L; Zhang X; Xu L
    BMC Ophthalmol; 2023 Sep; 23(1):384. PubMed ID: 37726700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentration of sodium tetradecyl sulfate and hypertonic glucose solution for the treatment of telangiectasia: A prospective randomized clinical trial.
    Bukina OV; Sinitsyn AA; Efremova OI; Pelevin AV
    Phlebology; 2023 Oct; 38(9):622-627. PubMed ID: 37519033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable chitosan hydrogel effectively controls lesion growth in a venous malformation murine model.
    Nguyen HL; Holderbaum Do Amaral R; Lerouge S; De Roo AK; Zehtabi F; Vikkula M; Soulez G
    Diagn Interv Imaging; 2024 Aug; ():. PubMed ID: 39095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy with 3% polidocanol foam in the treatment of hemorrhoidal disease: unveiling the missing pieces for a comprehensive evaluation.
    Gallo G; Dezi A; Grossi U; Picciariello A
    Front Surg; 2023; 10():1344724. PubMed ID: 38179315
    [No Abstract]   [Full Text] [Related]  

  • 16. Polidocanol Foam: A Breath of Fresh Air for the Treatment of Internal Hemorrhoids.
    Rosa B
    GE Port J Gastroenterol; 2019 May; 26(3):153-154. PubMed ID: 31192282
    [No Abstract]   [Full Text] [Related]  

  • 17. Polidocanol foam stability in terms of its association with glycerin.
    Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
    Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on Foam Decay Trend and Influence of Temperature Jump on Foam Stability in Sclerotherapy.
    Bai T; Chen Y; Jiang W; Yan F; Fan Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):98-106. PubMed ID: 29173136
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.